[Letter to J. Bennett Johnston from D. William Atwood]

9 TL.,:ZF I EF 1 4 -04/06/93 16:-24 -

002

"..
OFFICE, CHIEF OF
LEGISLATIVE LIAISON

DEPARTMENT OF THE ARMY
OFFICE OF THE SEC ETAPV 0- O,E ARMY
WASH,NGT0N. DC 2031-0-1600
April 2, 1993

Honorable J. Bennett Johnston
United States Senate
Washington, D. C. 20510
Dear Senator Johnston:
This replies to your letter to Secretary Aspin
concerning the progress of the gp160 Acquired
Immunodeficiency Syndrome (AIDS) vaccine trial which
$20 million was appropriated for in the National
Defense Appropriations Act for Fiscal Year 1993.
Army researchers, after consultation wiLh the
National Institutes of Health and the Food and Drug
Administration, are developiny a plan for conducting
Phase III testing of the gpl60 AIDS vaccine. The
United States Army Medical Research and Development
Command, as lead agency for Department of Defense AIDS
research, is currently conducting a cost analysis for a
Phase III trial of the gp160 vaccine. Upon completion
of this cost analysis, a request for proposals will be
issued and a contract awarded to conduct Phase III
testing. It is unlikely that a $20 million budget
will allow additional products to be evaluated.
I am enclosing an information paper that addresses
your specific questions.
Tihank you for your continued interest in this
matter, and I trust this information assists you.
Sincerely,

Wil1iam Atwood
Lieutenant Colonel, U. S. Army
Chief, Special Actions Branch
Congressional Inquiry Division

Enclosure

111111 l 55 lIJlI l 1 11111111111095.047.
5571095.0447.005